Kara S. Cox

1.9k total citations
30 papers, 1.0k citations indexed

About

Kara S. Cox is a scholar working on Epidemiology, Immunology and Infectious Diseases. According to data from OpenAlex, Kara S. Cox has authored 30 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 13 papers in Immunology and 12 papers in Infectious Diseases. Recurrent topics in Kara S. Cox's work include Respiratory viral infections research (9 papers), HIV Research and Treatment (8 papers) and Immunotherapy and Immune Responses (8 papers). Kara S. Cox is often cited by papers focused on Respiratory viral infections research (9 papers), HIV Research and Treatment (8 papers) and Immunotherapy and Immune Responses (8 papers). Kara S. Cox collaborates with scholars based in United States, Japan and Australia. Kara S. Cox's co-authors include Danilo R. Casimiro, Sheri Dubey, Kalpit A. Vora, Andrew J. Bett, Marian E. Gindy, Aimin Tang, Elizabeth Thoryk, John W. Shiver, Gokul Swaminathan and Michael Robertson and has published in prestigious journals such as Nature Medicine, The Journal of Immunology and PLoS ONE.

In The Last Decade

Kara S. Cox

30 papers receiving 985 citations

Peers

Kara S. Cox
John L. van Hamme Netherlands
Maureen F. Maughan United States
Yasemin Suezer Germany
Robert C. Colgrove United States
Christine M. Hay United States
Sam Hibbitts United Kingdom
Thomas D. Martin United States
David A. Hokey United States
Melanie Fiedler Germany
John L. van Hamme Netherlands
Kara S. Cox
Citations per year, relative to Kara S. Cox Kara S. Cox (= 1×) peers John L. van Hamme

Countries citing papers authored by Kara S. Cox

Since Specialization
Citations

This map shows the geographic impact of Kara S. Cox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kara S. Cox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kara S. Cox more than expected).

Fields of papers citing papers by Kara S. Cox

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kara S. Cox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kara S. Cox. The network helps show where Kara S. Cox may publish in the future.

Co-authorship network of co-authors of Kara S. Cox

This figure shows the co-authorship network connecting the top 25 collaborators of Kara S. Cox. A scholar is included among the top collaborators of Kara S. Cox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kara S. Cox. Kara S. Cox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deng, James Z., Zhifeng Chen, Yue Yuan, et al.. (2024). Identification and Quantification of a Pneumococcal Cell Wall Polysaccharide by Antibody-Enhanced Chromatography Assay. Vaccines. 12(5). 469–469. 3 indexed citations
2.
Feemster, Kristen A., Jessica Weaver, Ulrike K. Buchwald, et al.. (2023). Pneumococcal Vaccine Breakthrough and Failure in Infants and Children: A Narrative Review. Vaccines. 11(12). 1750–1750. 10 indexed citations
3.
Meyer, Brian K., Debbie Nahas, Andrew Danziger, et al.. (2023). Evaluation of luciferase and prefusion-stabilized F protein from respiratory syncytial virus mRNA/LNPs in pre-clinical models using jet delivery compared to needle and syringe. Vaccine X. 16. 100420–100420. 3 indexed citations
4.
Flynn, Jessica A., Teresa M. Weber, Pedro J. Cejas, et al.. (2022). Characterization of humoral and cell-mediated immunity induced by mRNA vaccines expressing influenza hemagglutinin stem and nucleoprotein in mice and nonhuman primates. Vaccine. 40(32). 4412–4423. 8 indexed citations
5.
Aliprantis, Antonios O., Christine A. Shaw, Paul Griffin, et al.. (2020). A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults. Human Vaccines & Immunotherapeutics. 17(5). 1248–1261. 111 indexed citations
6.
7.
Chen, Zhifeng, Kara S. Cox, Aimin Tang, et al.. (2018). Human monoclonal antibodies isolated from a primary pneumococcal conjugate Vaccinee demonstrates the expansion of an antigen-driven Hypermutated memory B cell response. BMC Infectious Diseases. 18(1). 613–613. 11 indexed citations
8.
Li, Hualin, Cheryl Callahan, Michael Citron, et al.. (2017). Respiratory syncytial virus elicits enriched CD8+ T lymphocyte responses in lung compared with blood in African green monkeys. PLoS ONE. 12(11). e0187642–e0187642. 17 indexed citations
9.
Clutton, Genevieve, Yinyan Xu, Pedro L. Baldoni, et al.. (2016). The differential short- and long-term effects of HIV-1 latency-reversing agents on T cell function. Scientific Reports. 6(1). 30749–30749. 51 indexed citations
10.
Meng, Weixu, Leike Li, Wei Xiong, et al.. (2015). Efficient generation of monoclonal antibodies from single rhesus macaque antibody secreting cells. mAbs. 7(4). 707–718. 18 indexed citations
11.
Cox, Kara S., Sheri Dubey, Joseph M. Antonello, et al.. (2015). Effector and Central Memory Poly-Functional CD4+ and CD8+ T Cells are Boosted upon ZOSTAVAX® Vaccination. Frontiers in Immunology. 6. 553–553. 41 indexed citations
12.
Cox, Kara S., Aimin Tang, Zhifeng Chen, et al.. (2015). Rapid isolation of dengue-neutralizing antibodies from single cell-sorted human antigen-specific memory B-cell cultures. mAbs. 8(1). 129–140. 28 indexed citations
13.
Swaminathan, Gokul, Elizabeth Thoryk, Kara S. Cox, et al.. (2015). A novel lipid nanoparticle adjuvant significantly enhances B cell and T cell responses to sub-unit vaccine antigens. Vaccine. 34(1). 110–119. 90 indexed citations
14.
Hutnick, Natalie A., Diane G. Carnathan, Sheri Dubey, et al.. (2010). Vaccination with Ad5 Vectors Expands Ad5-Specific CD8+ T Cells without Altering Memory Phenotype or Functionality. PLoS ONE. 5(12). e14385–e14385. 10 indexed citations
15.
Schooley, Robert T., John Spritzler, Hongying Wang, et al.. (2010). AIDS Clinical Trials Group 5197: A Placebo‐Controlled Trial of Immunization of HIV‐1–Infected Persons with a Replication‐Deficient Adenovirus Type 5 Vaccine Expressing the HIV‐1 Core Protein. The Journal of Infectious Diseases. 202(5). 705–716. 76 indexed citations
16.
Finnefrock, Adam C., Aimin Tang, Fengsheng Li, et al.. (2009). PD-1 Blockade in Rhesus Macaques: Impact on Chronic Infection and Prophylactic Vaccination. The Journal of Immunology. 182(2). 980–987. 100 indexed citations
17.
Hutnick, Natalie A., Diane G. Carnathan, Sheri Dubey, et al.. (2009). Baseline Ad5 serostatus does not predict Ad5 HIV vaccine–induced expansion of adenovirus-specific CD4+ T cells. Nature Medicine. 15(8). 876–878. 71 indexed citations
18.
Cox, Kara S., James H. Clair, Kara J. Sykes, et al.. (2008). DNA gag/Adenovirus Type 5 (Ad5) gag and Ad5 gag/Ad5 gag Vaccines Induce Distinct T-Cell Response Profiles. Journal of Virology. 82(16). 8161–8171. 41 indexed citations
19.
Chavez, L. L., Miles P. Davenport, John W. Shiver, et al.. (2008). The effect of early versus delayed challenge after vaccination in controlling SHIV 89.6P infection. Virology. 381(1). 75–80. 1 indexed citations
20.
Tobery, Timothy W., Sheri Dubey, Daniel C. Freed, et al.. (2006). A Comparison of Standard Immunogenicity Assays for Monitoring HIV Type 1 gag-Specific T Cell Responses in Ad5 HIV Type 1 gag Vaccinated Human Subjects. AIDS Research and Human Retroviruses. 22(11). 1081–1090. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John L. van Hamme Breakdown of academic impact, for papers by Maureen F. Maughan Breakdown of academic impact, for papers by Yasemin Suezer Breakdown of academic impact, for papers by Robert C. Colgrove Breakdown of academic impact, for papers by Christine M. Hay Breakdown of academic impact, for papers by Sam Hibbitts Breakdown of academic impact, for papers by Thomas D. Martin Breakdown of academic impact, for papers by David A. Hokey Breakdown of academic impact, for papers by Melanie Fiedler
Rankless by CCL
2026